Oxidative damage of vascular smooth muscle cells by the glycated protein-cupric ion system

Atherosclerosis

Volumn 136, Issue 2, 1998, Pages 263-274

  Sakata, Noriyuki ^a   Miyamoto, Koji ^a   Meng, Jing ^a   Tachikawa, Yutaka ^a   Imanaga, Yoshinobu ^a   Takebayashi, Shigeo ^a   Furukawa, Tatsuo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Atherogenesis; Cell injury; Glycation; Oxidation; Reactive oxygen species; Smooth muscle cells

Indexed keywords

BOVINE SERUM ALBUMIN; COPPER ION; REACTIVE OXYGEN METABOLITE; RHODAMINE 123; ZINC;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; GLYCATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

ANIMALS; CATALASE; CELLS, CULTURED; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; MANNITOL; MUSCLE, SMOOTH, VASCULAR; OXIDANTS; REACTIVE OXYGEN SPECIES; SERUM ALBUMIN, BOVINE; SPECTROMETRY, FLUORESCENCE; SUPEROXIDE DISMUTASE; SWINE; TIRON;

EID: 0032005423     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00219-0     Document Type: Article

References (45)

1. Pyorala K., Laakso, Unsitupa M. Diabetes and arteriosclerosis: an epidemiologic view. Diabetes Metab Rev. 3:1987;463.
2. Rahbar S. An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta. 22:1968;296.
3. Day J.F., Thorpe S.R., Baynes J.W. Nonenzymatically glucosylated albumin in vitro preparation and isolation from normal human serum. J Biol Chem. 254:1979;595.
4. Witztum J.L., Mahoney E.M., Branks M.J., Fisher M., Elam R., Steinberg D. Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes. 31:1982;283.
5. Sakata N., Meng J., Jimi S., Takebayashi S. Nonenzymatic glycation and extractability of collagen in human atherosclerotic plaques. Atherosclerosis. 116:1995;63.
6. MacDonald E., Lee W.K., Hepburn S., Bell J., Scott P.J.W., Dominiczak M.H. Advanced glycosylation end products in the mesenteric artery. Clin Chem. 38:1992;530.
7. Araki N., Ueno Y., Chakrabarti B., Morino Y., Horiuchi S. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem. 267:1992;10211.
8. Vlassara H., Brownlee M., Cerami A. Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Proc Natl Acad Sci USA. 78:1981;5190.
9. Yui S., Sasaki T., Araki H., Horiuchi S., Yamazaki M. Induction of macrophage growth by advanced end products of the Maillard reaction. J Immunol. 152:1994;1943.
10. Doi T., Vlassara H., Kirstein M., Yamada Y., Striker G.E., Striker L.J. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA. 89:1992;2873.
11. Vlassara H., Brownlee M., Manogue K.R., Dinarello C., Pasagian A. Cachectin/TNF and IL-1 induced by glucose modified proteins: role in normal tissue remodeling. Science. 240:1988;1546.
12. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., Pinsky D., Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 269:1994;9889.
13. Pieper G.M., Gross G. Oxygen-derived free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol. 255:1988;H825.
14. Sakurai T., Kimura S., Nakano M., Kimura H. Oxidative modification of glycated low density lipoprotein in the presence of iron. Biochem Biophys Res Commun. 177:1991;433.
15. Cheng R.Z., Uchida K., Kawakishi S. Selective oxidation of histidine residues in proteins or peptides through the copper(II)-catalysed autoxidation of glucosone. Biochem J. 285:1992;667.
16. Millican S.A., Bagga M., Eddy R., Mitchinson M.J., Hunt J.V. Effect of glucose-mediated LDL oxidation on the P388D1 macrophage-like cell line. Atherosclerosis. 129:1997;17.
17. Demuth K., Myara I., Chappey B., Vedie B., Pech-Amsellem M.A., Haberland M.E., Moatti N. A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscler Thromb Vasc Biol. 16:1996;773.
18. Elgawish A., Glomb M., Friedlander M., Monnier V.M. Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J Biol Chem. 271:1996;12964.
19. Sakata N., Jimi S., Takebayashi S., Marques M.A. Type V collagen represses the attachment, spread, and growth of porcine vascular smooth muscle cells in vitro. Exp Mol Pathol. 56:1992;20.
20. Horiuchi S., Araki N., Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J Biol Chem. 266:1991;7329.
21. Johnson R.N., Metcalf P.A., Baker J.R. Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta. 127:1982;87.
22. Clare K., Hardwick S.J., Carpenter K.L.M., Weeratunge N., Mitchinson M.J. Toxicity of oxysterols to human monocyte-macrophages. Atherosclerosis. 118:1995;67.
23. Henderson L.M., Chappell J.B. Dihydrorhodamine 123: a fluorescent probe for superoxide generation? Eur J Biochem. 217:1993;973.
24. Bass D.A., Parce J.W., Dechatelet L.R., Szjda P., Seeds M.C., Thomas M. Flow cytometric studies of oxidative product formation by neutrophils; a graded response to membrane stimulation. J Immunol. 130:1983;1910.
25. Sakurai T., Tsuchiya S. Superoxide production from nonenzymatically glycated protein. FEBS Lett. 236:1988;406.
26. Halliwell B. Oxidants and human disease: some new concepts. FASEB J. 1:1987;358.
27. Nakayama T., Terazawa K., Kawakishi S. Cytotoxicity of glucosone in the presence of cupric ion. J Agric Food Chem. 40:1992;830.
28. Smith C., Mitchinson M.J., Aruoma O.I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J. 286:1992;901.
29. Wolff S.P., Dean R.T. Glucose autoxidation and protein modification. The potential role of oxidative glycosylation in diabetes. Biochem J. 245:1987;243.
30. Sing D.J., Greenwald J., Metz E.N., Bianchine J., Sagone A.L. Evidence for the generation of hydroxyl radical during arachidonic acid metabolism by human platelets. Am J Hematol. 11:1981;233.
31. Mullarkey C.J., Edelstein D., Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun. 173:1990;932.
32. Kawakishi S., Okawa Y., Uchida K. Oxidative damage of protein induced by the Amadori compound-copper ion system. J Agric Food Chem. 38:1990;13.
33. Kawakishi S., Tsunehiro J., Uchida K. Autoxidative degradation of Amadori compounds in the presence of copper ion. Carbhydr Res. 211:1991;167.
34. Hunt J.V., Dean R.T., Wolff S.P. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging. Biochem J. 256:1988;205.
35. Block E.R. Hydrogen peroxide alters the physical state and function of the plasma membrane of pulmonary artery endothelium. J Cell Physiol. 146:1991;362.
36. Leff J.A., Oppegard M.A., Terada L.S., McCarty E.C., Repine J.E. Human serum catalase decreases endothelial cell injury from hydrogen peroxide. J Appl Physiol. 71:1991;1903.
37. Taniguchi N. Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia and cancer. Adv Clin Chem. 29:1992;1.
38. Fujii J., Myint T., Okado A., Kaneto H., Taniguchi N. Oxidative stress caused by glycation of Cu, Zn-superoxide dismutase and its effects on intracellular components. Nephrol Dial Transplant. 11(5):1996;34.
39. Ookawara T., Kawamura N., Kitagawa Y., Taniguchi N. Site-specific and random fragmentation of Cu, Zn-superoxide dismutase by glycation reaction. J Biol Chem. 267:1992;18505.
40. Short R., Williams D.D., Bowden D.M. Circulating antioxidants as determinants of the rate of biological aging in pigtailed macaques (Macaca nemestrina). J Gerontol A Biol Sci Med Sci. 52:1997;B26.
41. Baker J.R., Metcalf P.A., Johnson R.N., Newman D., Rietz P. Use of protein-based standards in automated colorimetric determinations of fructosamine in serum. Clin Chem. 31:1985;1550.
42. Hunt J.V., Skamarauskas J.T., Mitchinson M.J. Protein glycation and fluorescent material in human atheroma. Atherosclerosis. 111:1994;255.
43. Stadtman E.R. Protein oxidation and aging. Science. 257:1992;1220.
44. Ehrenwald E., Chisolm G.M., Fox P.L. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest. 93:1994;1493.
45. Bégin M.E., Ellis G., Horrobin D.F. Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst. 80:1988;188.